NewsRx

Search our medical news database

Action Plan

FDA inspection results still unknown

Published in Medical Letter on the CDC and FDA, November 3rd, 2002

On July 29, 2002, Alpharma, Inc., (ALO), a leading global specialty pharmaceutical company, announced that the FDA was completing a follow-up inspection to a September 2001 inspection of its Baltimore plant.

The results of the inspection were not known at the time. The FDA recently issued a reinspection report. Based on the company's initial assessment of the report, the company believes that the remedial action plan put in place following the September 2001 inspection must be expanded in scope and extended in duration and certain other actions may need to be taken to comply with FDA regulations.

Until the company fully formulates its revised...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook